228 related articles for article (PubMed ID: 16296718)
1. Growth factor delivery for bone tissue repair: an update.
Varkey M; Gittens SA; Uludag H
Expert Opin Drug Deliv; 2004 Nov; 1(1):19-36. PubMed ID: 16296718
[TBL] [Abstract][Full Text] [Related]
2. Localized delivery of growth factors for bone repair.
Luginbuehl V; Meinel L; Merkle HP; Gander B
Eur J Pharm Biopharm; 2004 Sep; 58(2):197-208. PubMed ID: 15296949
[TBL] [Abstract][Full Text] [Related]
3. Critical aspects of tissue-engineered therapy for bone regeneration.
Doll B; Sfeir C; Winn S; Huard J; Hollinger J
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):173-98. PubMed ID: 11693960
[TBL] [Abstract][Full Text] [Related]
4. Bone tissue engineering by gene delivery.
Kofron MD; Laurencin CT
Adv Drug Deliv Rev; 2006 Jul; 58(4):555-76. PubMed ID: 16790291
[TBL] [Abstract][Full Text] [Related]
5. Toward delivery of multiple growth factors in tissue engineering.
Chen FM; Zhang M; Wu ZF
Biomaterials; 2010 Aug; 31(24):6279-308. PubMed ID: 20493521
[TBL] [Abstract][Full Text] [Related]
6. Virus-based gene therapy strategies for bone regeneration.
Phillips JE; Gersbach CA; García AJ
Biomaterials; 2007 Jan; 28(2):211-29. PubMed ID: 16928397
[TBL] [Abstract][Full Text] [Related]
7. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
[TBL] [Abstract][Full Text] [Related]
8. Temporally controlled multiple-gene delivery in scaffolds: A promising strategy to enhance bone regeneration.
Liu J; Xu L; Li Y; Ma J
Med Hypotheses; 2011 Feb; 76(2):173-5. PubMed ID: 20926199
[TBL] [Abstract][Full Text] [Related]
9. Future of local bone regeneration - Protein versus gene therapy.
Fischer J; Kolk A; Wolfart S; Pautke C; Warnke PH; Plank C; Smeets R
J Craniomaxillofac Surg; 2011 Jan; 39(1):54-64. PubMed ID: 20434921
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials of drug delivery systems for tissue regeneration.
Tabata Y
Methods Mol Biol; 2005; 300():81-100. PubMed ID: 15657480
[TBL] [Abstract][Full Text] [Related]
11. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
[TBL] [Abstract][Full Text] [Related]
12. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery.
Haidar ZS; Hamdy RC; Tabrizian M
Biotechnol Lett; 2009 Dec; 31(12):1817-24. PubMed ID: 19690804
[TBL] [Abstract][Full Text] [Related]
13. Bone repair: new developments in growth factor delivery systems and their mathematical modeling.
Lauzon MA; Bergeron E; Marcos B; Faucheux N
J Control Release; 2012 Sep; 162(3):502-20. PubMed ID: 22889715
[TBL] [Abstract][Full Text] [Related]
14. Designing proteins for bone targeting.
Gittens SA; Bansal G; Zernicke RF; Uludağ H
Adv Drug Deliv Rev; 2005 May; 57(7):1011-36. PubMed ID: 15876401
[TBL] [Abstract][Full Text] [Related]
15. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.
Lee SH; Shin H
Adv Drug Deliv Rev; 2007 May; 59(4-5):339-59. PubMed ID: 17499384
[TBL] [Abstract][Full Text] [Related]
16. Protein-based tissue engineering in bone and cartilage repair.
Wozney JM; Seeherman HJ
Curr Opin Biotechnol; 2004 Oct; 15(5):392-8. PubMed ID: 15464367
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.
Liu HW; Chen CH; Tsai CL; Hsiue GH
Bone; 2006 Oct; 39(4):825-36. PubMed ID: 16782421
[TBL] [Abstract][Full Text] [Related]
18. Administration of growth factors for bone regeneration.
Yun YR; Jang JH; Jeon E; Kang W; Lee S; Won JE; Kim HW; Wall I
Regen Med; 2012 May; 7(3):369-85. PubMed ID: 22594329
[TBL] [Abstract][Full Text] [Related]
19. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix.
Han D; Liu W; Ao Q; Wang G
Med Hypotheses; 2008 Sep; 71(3):374-8. PubMed ID: 18565684
[TBL] [Abstract][Full Text] [Related]
20. Growth factors and bone regeneration: how much bone can we expect?
Nauth A; Ristevski B; Li R; Schemitsch EH
Injury; 2011 Jun; 42(6):574-9. PubMed ID: 21489530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
